Tomoko Fujiyuki
Meguro, 1538505, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 22 publications
Expression of PVRL4, a molecular target for cancer treatment, is transcriptionally regulated by FOS.
Expression of PVRL4, a molecular target for cancer treatment, is transcriptionally regulated by FOS.
Journal: Oncology reports
Published: April 27, 2023
Anti-tumor activity of a recombinant measles virus against canine lung cancer cells.
Journal: Scientific reports
Published: October 26, 2022
Gene expression of Nectin-4 and its clinical significance in dogs with primary lung adenocarcinoma.
Journal: Veterinary medicine and science
Published: July 29, 2022
Immune response elicited in the tumor microenvironment upon rMV-SLAMblind cancer virotherapy.
Journal: Cancer science
Published: March 07, 2022
Recombinant SLAMblind Measles Virus Is a Promising Candidate for Nectin-4-Positive Triple Negative Breast Cancer Therapy.
Journal: Molecular therapy oncolytics
Published: February 07, 2020
Antitumor activity of an oncolytic measles virus against canine urinary bladder transitional cell carcinoma cells.
Journal: Research in veterinary science
Published: February 06, 2020
Non-pathogenic Escherichia coli acquires virulence by mutating a growth-essential LPS transporter.
Journal: PLoS pathogens
Published: July 10, 2019
Efficacy of recombinant measles virus expressing highly pathogenic avian influenza virus (HPAIV) antigen against HPAIV infection in monkeys.
Journal: Scientific reports
Published: January 27, 2017
Measles virus selectively blind to signaling lymphocyte activity molecule has oncolytic efficacy against nectin-4-expressing pancreatic cancer cells.
Journal: Cancer science
Published: March 30, 2016
Last Updated: 09/26/2026